- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in developing MNK inhibitors
Authors
Keywords
MNK, eIF4E, Antitumor activity, Protein kinase inhibitors
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 219, Issue -, Pages 113420
Publisher
Elsevier BV
Online
2021-04-03
DOI
10.1016/j.ejmech.2021.113420
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2
- (2020) Jacek Kwiatkowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- MAPK-interacting kinase 2 (MNK2) regulates adipocyte metabolism independently of its catalytic activity
- (2020) James E. Merrett et al. BIOCHEMICAL JOURNAL
- The cytokine storm and COVID‐19
- (2020) Biying Hu et al. JOURNAL OF MEDICAL VIROLOGY
- Newcastle Disease virus infection activates PI3K/Akt/mTOR and p38 MAPK/Mnk1 pathways to benefit viral mRNA translation via interaction of the viral NP protein and host eIF4E
- (2020) Yuan Zhan et al. PLoS Pathogens
- Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity
- (2020) Lauren Y. Sandeman et al. Molecular Metabolism
- Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia
- (2020) Liang-Chieh Chen et al. JOURNAL OF NATURAL PRODUCTS
- MNK1/NODAL signaling promotes invasive progression of breast ductal carcinoma in situ
- (2019) Qianyu Guo et al. CANCER RESEARCH
- The MAP kinase-interacting kinases (MNKs) as targets in oncology
- (2019) Jianling Xie et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Translation control of the immune checkpoint in cancer and its therapeutic targeting
- (2019) Yichen Xu et al. NATURE MEDICINE
- The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis
- (2019) Senthilmurugan Ramalingam et al. Cancers
- Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma
- (2019) Min Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and evaluation of 2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione derivatives as Mnk inhibitors
- (2019) Ahmed M. Abdelaziz et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- First‐in‐Human, Healthy Volunteers Integrated Protocol of ETC‐206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
- (2019) Vincenzo Teneggi et al. CTS-Clinical and Translational Science
- Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
- (2019) Solène Fernandez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Eukaryotic initiation factor 4E (eIF4E): A recap of the cap‐binding protein
- (2019) Asiya Batool et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Discovery of novel Mnk inhibitors using mutation‐based induced‐fit virtual high‐throughput screening
- (2019) Rama K. Mishra et al. Chemical Biology & Drug Design
- Reversal of peripheral nerve injury-induced neuropathic pain and cognitive dysfunction via genetic and tomivosertib targeting of MNK
- (2019) Stephanie Shiers et al. NEUROPSYCHOPHARMACOLOGY
- Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo
- (2019) Andrew K. Kwegyir-Afful et al. Cancers
- Deciphering the mechanistic effects of eIF4E phosphorylation on mRNA‐cap recognition
- (2019) Dilraj Lama et al. PROTEIN SCIENCE
- Inhibitory effects of SEL201 in acute myeloid leukemia
- (2019) Ewa M. Kosciuczuk et al. Oncotarget
- The retinamide VNLG-152 inhibits f-AR/AR-V7 and MNK-eIF4E signaling pathways to suppress EMT and castration-resistant prostate cancer xenograft growth
- (2018) Vidya P. Ramamurthy et al. FEBS Journal
- Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition
- (2018) Siegfried H. Reich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia
- (2018) Haiyan Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Loss of eIF4E phosphorylation engenders depression-like behaviors via selective mRNA translation
- (2018) Inês Silva Amorim et al. JOURNAL OF NEUROSCIENCE
- Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils
- (2018) Nathaniel Robichaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of MAPK/MNK1 signaling in virus replication
- (2018) Ram Kumar et al. VIRUS RESEARCH
- Therapeutic Opportunities in Eukaryotic Translation
- (2018) Jennifer Chu et al. Cold Spring Harbor Perspectives in Biology
- Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
- (2018) Argel Aguilar-Valles et al. Nature Communications
- Synergistic effects of inhibiting the MNK-eIF4E and PI3K/AKT/ mTOR pathways on cell migration in MDA-MB-231 cells
- (2018) Ella Lineham et al. Oncotarget
- Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer
- (2018) Celia Pinto-Díez et al. Oncotarget
- A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1
- (2018) Yumi Matsui et al. Acta Crystallographica Section F-Structural Biology Communications
- eIF4E Phosphorylation in Prostate Cancer
- (2018) Leandro S. D'Abronzo et al. NEOPLASIA
- Probing the Anticancer Action of Novel Ferrocene Analogues of MNK Inhibitors
- (2018) Supojjanee Sansook et al. MOLECULES
- MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells
- (2018) Xian-bo Huang et al. ACTA PHARMACOLOGICA SINICA
- MNK1 inhibitor as an antiviral agent suppresses buffalopox virus protein synthesis
- (2018) Ram Kumar et al. ANTIVIRAL RESEARCH
- Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold
- (2018) Xin Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming
- (2017) Phillip A. Geter et al. GENES & DEVELOPMENT
- MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma
- (2017) Yao Zhan et al. JOURNAL OF CLINICAL INVESTIGATION
- The MNK–eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain
- (2017) Jamie K. Moy et al. JOURNAL OF NEUROSCIENCE
- Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
- (2017) Jonathan B. Bell et al. MOLECULAR CANCER RESEARCH
- The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer
- (2017) L S D'Abronzo et al. ONCOGENE
- Brd4 modulates the innate immune response through Mnk2–eIF4E pathway-dependent translational control of IκBα
- (2017) Yan Bao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma
- (2017) Weiyuan Wang et al. Theranostics
- MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1
- (2017) Michael C. Brown et al. Cell Reports
- MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer
- (2017) Zhihua Guo et al. Scientific Reports
- Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway
- (2016) Zhong Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma
- (2016) Yongdong Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo
- (2016) E. M. Kosciuczuk et al. BLOOD
- Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma
- (2016) Julia H Carter et al. BRITISH JOURNAL OF CANCER
- The MNK-1/eIF4E pathway as a new therapeutic pathway to target inflammation and remodelling in asthma
- (2016) Petra Seidel et al. CELLULAR SIGNALLING
- Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
- (2016) Michal Grzmil et al. CELLULAR SIGNALLING
- Galeterone and VNPT55 disrupt Mnk-eIF4E to inhibit prostate cancer cell migration and invasion
- (2016) Andrew K. Kwegyir-Afful et al. FEBS Journal
- Unveiling new chemical scaffolds as Mnk inhibitors
- (2016) Sarah Diab et al. Future Medicinal Chemistry
- Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
- (2016) Wooseok Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells
- (2016) Joseph Cherian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- Tuning Specific Translation in Cancer Metastasis and Synaptic Memory: Control at the MNK–eIF4E Axis
- (2016) Clive R. Bramham et al. TRENDS IN BIOCHEMICAL SCIENCES
- CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway
- (2016) Qiuyuan Wen et al. Oncotarget
- eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
- (2016) Ting Liu et al. Oncotarget
- Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice
- (2016) Andrew K. Kwegyir-Afful et al. Oncotarget
- MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways
- (2016) C. E. J. Moore et al. Scientific Reports
- peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
- (2016) Elena Martínez-Sáez et al. Cancer Medicine
- The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding
- (2015) James E. Beggs et al. BIOCHEMICAL JOURNAL
- Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells
- (2015) Theodosia Teo et al. CANCER LETTERS
- Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer
- (2015) B. Montgomery et al. CLINICAL CANCER RESEARCH
- An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis
- (2015) Theodosia Teo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation
- (2015) Mingfeng Yu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel C-4 Heteroaryl 13-cis-Retinamide Mnk/AR Degrading Agents Inhibit Cell Proliferation and Migration and Induce Apoptosis in Human Breast and Prostate Cancer Cells and Suppress Growth of MDA-MB-231 Human Breast and CWR22Rv1 Human Prostate Tumor Xenografts in Mice
- (2015) Hannah W. Mbatia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Development of Galeterone (TOK-001 or VN/124-1) for the Treatment of All Stages of Prostate Cancer
- (2015) Vincent C. O. Njar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
- (2015) H Wu et al. LEUKEMIA
- Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
- (2015) Xiaodi Su et al. NATURE IMMUNOLOGY
- Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines
- (2015) Vidya P. Ramamurthy et al. Oncotarget
- Discovery of 5-(2-(Phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation
- (2014) Sarah Diab et al. ChemMedChem
- Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3
- (2014) N Robichaud et al. ONCOGENE
- MNK1-Induced eIF-4E Phosphorylation in Myeloma Cells: A Pathway Mediating IL-6-Induced Expansion and Expression of Genes Involved in Metabolic and Proteotoxic Responses
- (2014) Yijiang Shi et al. PLoS One
- Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors
- (2013) J. K. Altman et al. BLOOD
- Rational Design of Resorcylic Acid Lactone Analogues as Covalent MNK1/2 Kinase Inhibitors by Tuning the Reactivity of an Enamide Michael Acceptor
- (2013) Jin Xu et al. ChemMedChem
- Translational control of human neutrophil responses by MNK1
- (2013) Carl F. Fortin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
- (2013) S. Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
- (2012) S. Betty Yan et al. INVESTIGATIONAL NEW DRUGS
- Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E
- (2012) Barbara Herdy et al. NATURE IMMUNOLOGY
- Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases
- (2011) B. W. Konicek et al. CANCER RESEARCH
- Exploring Aigialomycin D and Its Analogues as Protein Kinase Inhibitors for Cancer Targets
- (2011) Jin Xu et al. ACS Medicinal Chemistry Letters
- Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues
- (2010) Songqing Fan et al. CANCER BIOLOGY & THERAPY
- Targeting the eIF4F translation initiation complex for cancer therapy
- (2010) Bruce W. Konicek et al. CELL CYCLE
- Essential Role for Mnk Kinases in Type II Interferon (IFNγ) Signaling and Its Suppressive Effects on Normal Hematopoiesis
- (2010) Sonali Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Oriented Virtual Screening Approach
- (2010) Julen Oyarzabal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development
- (2010) T. Ueda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
- (2010) L. Furic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mnk earmarks eIF4E for cancer therapy
- (2010) N. Hay PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
- (2009) J. R. Graff et al. CANCER RESEARCH
- Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses
- (2009) S. Joshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells
- (2008) Andrea Bianchini et al. CARCINOGENESIS
- The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases)
- (2008) Maria Buxade Frontiers in Bioscience-Landmark
- Inhibition of Polysome Assembly Enhances Imatinib Activity against Chronic Myelogenous Leukemia and Overcomes Imatinib Resistance
- (2008) M. Zhang et al. MOLECULAR AND CELLULAR BIOLOGY
- 17 -Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response
- (2008) R. D. Bruno et al. MOLECULAR CANCER THERAPEUTICS
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages
- (2007) Robert M. Rowlett et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started